[author: Pamela Koenig]
A promising new technology may make the diagnosis of cancer and genetic mutation testing as easy as performing a urinalysis as part of an annual physical exam. Cancer could be detected at its earliest stages, when treatment responses would be more favorable and better outcomes more likely.
Scientists at the Translational Genomics Research Institute (TGen), an affiliate of the City of Hope, one of the nation’s elite cancer hospitals in California, have discovered a way to pinpoint early stage cancer by analyzing short strands of small pieces of DNA known as cell-free DNA (cfDNA) in urine. Previously, researchers had believed that DNA fragments in urine were highly degraded and were too short to provide much useful information about cancer. However, the team of researchers, led by Dr. Muhammed Murtaza from TGen and City of Hope, along with other colleagues from Baylor University and Phoenix Children s Hospital, found that the DNA fragments in urine were
Arizona pets to be subject of coronavirus study at TGen lab
TGen is looking for pets around the Valley to take part in a study about coronavirus and its impacts on animals.
and last updated 2021-03-11 13:59:32-05
PHOENIX â The Translational Genomics Research Institute (TGen) is now testing pets of Arizonans who have contracted COVID-19 in order to better track and understand the virus. Among the more than 120 pets that have tested positive nationwide, there is no evidence suggesting that pets can spread the virus to humans, TGen stated. However, the full impact of coronavirus on animals is not yet known.
E-Mail
IMAGE: Hayley Yaglom, TGen genomic epidemiologist and lead researcher on a project to test pets for COVID-19, takes a blood sample from a dog. view more
Credit: Photo: Courtesy of TGen.
PHOENIX, Ariz. March 10, 2021 The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, announced today the start a new scientific study: Testing pets of those Arizonans who have contracted COVID-19.
No pets will be harmed during this study as all sample collections will be performed by trained veterinary staff. Among the more than 120 pets that have tested positive nationwide, there is no evidence suggesting that pets can spread the virus to humans.
Share:
Ark Funds hosted an investor webinar Tuesday, sharing ideas on several industries and portfolio components, including a discussion on some names in the genomics space.
Ark Funds On Genomics: Ark Funds is well-known for its bullish thesis on the genomics market. The company has the Ark Genomic Revolution ETF (BATS: ARKG), an ETF devoted to the growth of the segment.
Exact Sciences (NASDAQ: EXAS) was highlighted by Ark Funds analyst Simon Barnett.
The company has made a series of acquisitions that could help the company’s position in the market, he said.
“Incorporating it all together, Exact can broaden out their portfolio [and] determine market share.”